Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Sage Therapeutics, Inc.    SAGE

SAGE THERAPEUTICS, INC.

(SAGE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

SAGE THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
08/10/2020 | 07:03am EDT

Item 2.02 Results of Operations and Financial Condition

On August 10, 2020, Sage Therapeutics, Inc. announced its financial results for the quarter ended June 30, 2020. A copy of the press release is being furnished as Exhibit 99.1 to this Report on Form 8-K.

The information in this Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits



Exhibit
  No.       Description

99.1          Press release issued by Sage Therapeutics, Inc. on August 10, 2020,
            furnished herewith.

104         Cover Page Interactive Data File (embedded within the Inline XBRL
            document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses


share with twitter share with LinkedIn share with facebook
All news about SAGE THERAPEUTICS, INC.
05:01pSAGE THERAPEUTICS : to Report Third Quarter 2020 Financial Results on Thursday, ..
BU
10/16SAGE THERAPEUTICS : Announces Positive Interim, Topline Zuranolone Safety and To..
AQ
10/15SAGE THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form ..
AQ
10/15SAGE THERAPEUTICS : Announces Positive Interim, Topline Zuranolone Safety and To..
BU
10/02SAGE THERAPEUTICS : Appoints Barry Greene to Board of Directors
AQ
10/01SAGE THERAPEUTICS, INC. : Change in Directors or Principal Officers, Other Event..
AQ
10/01SAGE THERAPEUTICS : Appoints Barry Greene to Board of Directors
BU
09/10SAGE THERAPEUTICS : rsquo; FutureCast to Provide Update on Pipeline Progression ..
BU
09/01SAGE THERAPEUTICS : to Present at Morgan Stanley 18th Annual Global Healthcare C..
BU
08/20SAGE THERAPEUTICS : to Host Sage FutureCast Webcast
BU
More news